Value contribution of Etranacogene dezaparvovec for the treatment of severe and moderately severe haemophilia B in Spain through multicriteria decision analysis (MCDA)

被引：0

作者：

Garcia Diego, Daniel-Anibal ^{[1
]}

Jimenez-Yuste, Victor ^{[2
]}

Nunez Vazquez, Ramiro ^{[3
]}

Benitez Hidalgo, Olga ^{[4
]}

Luis Poveda, Jose ^{[5
]}

Juarez Gimenez, Juan Carlos ^{[6
]}

Luis Trillo, Jose ^{[7
]}

Valles, Joan-Antoni ^{[8
]}

Perez-Santamarina, Rafael ^{[9
]}

Badia, Xavier ^{[10
]}

机构：

[1] Fedhemo Fedrat Espanola Hemofilia, Madrid, Spain

[2] Univ Autonoma, Hosp Univ Paz IdiPaz, Madrid, Spain

[3] Hosp Univ Virgen Rocio, Seville, Spain

[4] Vall dHebron Hosp, Barcelona, Spain

[5] Hosp Univ & La Politecn Fe, Valencia, Spain

[6] Vall dHebron Hosp, Barcelona, Spain

[7] Malvarrosa Clin Dept Valencia, Valencia, Spain

[8] Inst Catala Salut ICS, Barcelona, Spain

[9] Hosp Univ La Paz, Madrid, Spain

[10] Omakase Consulting, Barcelona, Spain

来源：

关键词：

gene therapy; haemophilia B; Multicriteria Decision Analysis (MCDA);

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

MP-024 (17

引用

页码：62 / 62

页数：1